Skip to main content

Table 3 Comparison of serum miR-21 expression and CA-125 serum levels among patients and controls

From: Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

 

Patients (n = 50)

Controls (n = 50)

p

miR-21

Mean ± SD

5.54 ± 1.87

1.1 ± 0.43

 < 0.001

CA125

Median

478

44

 

Range

19–1325

10–477

 < 0.001